Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Apr 1;99(7):1606–1613. doi: 10.1172/JCI119323

A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.

H H Wittrup 1, A Tybjaerg-Hansen 1, S Abildgaard 1, R Steffensen 1, P Schnohr 1, B G Nordestgaard 1
PMCID: PMC507980  PMID: 9120004

Abstract

Lipoprotein lipase degrades triglycerides in plasma and as a byproduct produces HDL particles. Genetic variation in lipoprotein lipase may therefore affect cardiovascular risk. We tested 9,214 men and women from a general population sample and 948 patients with ischemic heart disease for the Asn291Ser substitution in lipoprotein lipase. The allele frequency in the general population was 0.024 and 0.026 for women and men, respectively. In comparison with noncarriers, female heterozygous probands had increased plasma triglycerides (delta = 0.23 mmol/liter), while HDL cholesterol was reduced in both female and male carriers (delta = 0.18 mmol/liter and delta = 0.11 mmol/liter, respectively). A similar phenotype was found in six homozygous carriers. On multiple logistic regression analysis, plasma triglycerides and HDL cholesterol were independent predictors of ischemic heart disease in both genders. On univariate analysis, odds ratios for ischemic heart disease in probands were 1.89 in women (95% CI: 1.19-3.01) and 0.90 in men (95% CI: 0.62-1.31), and on multivariate analysis were 1.98 in women (95% CI: 1.11-3.53) and 1.02 in men (95% CI: 0.65-1.60). This study demonstrates that a single common mutation in the lipoprotein lipase gene is associated with elevated plasma triglycerides and reduced HDL cholesterol levels, whereby carriers, in particular women, seem to be predisposed to ischemic heart disease. It cannot be excluded, however, that male carriers of this substitution may represent a subset of low-HDL individuals without raised triglycerides not predisposed to ischemic heart disease.

Full Text

The Full Text of this article is available as a PDF (175.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austin M. A. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991 Jan-Feb;11(1):2–14. doi: 10.1161/01.atv.11.1.2. [DOI] [PubMed] [Google Scholar]
  2. Barter P. J., Rye K. A. High density lipoproteins and coronary heart disease. Atherosclerosis. 1996 Mar;121(1):1–12. doi: 10.1016/0021-9150(95)05675-0. [DOI] [PubMed] [Google Scholar]
  3. Benlian P., De Gennes J. L., Foubert L., Zhang H., Gagné S. E., Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med. 1996 Sep 19;335(12):848–854. doi: 10.1056/NEJM199609193351203. [DOI] [PubMed] [Google Scholar]
  4. Buscà R., Peinado J., Vilella E., Auwerx J., Deeb S. S., Vilaró S., Reina M. The mutant Asn291-->Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin. FEBS Lett. 1995 Jul 3;367(3):257–262. doi: 10.1016/0014-5793(95)00582-t. [DOI] [PubMed] [Google Scholar]
  5. Fisher R. M., Mailly F., Peacock R. E., Hamsten A., Seed M., Yudkin J. S., Beisiegel U., Feussner G., Miller G., Humphries S. E. Interaction of the lipoprotein lipase asparagine 291-->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res. 1995 Oct;36(10):2104–2112. [PubMed] [Google Scholar]
  6. Funke H., Assmann G. The low down on lipoprotein lipase. Nat Genet. 1995 May;10(1):6–7. doi: 10.1038/ng0595-6. [DOI] [PubMed] [Google Scholar]
  7. Goldberg I. J. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996 Apr;37(4):693–707. [PubMed] [Google Scholar]
  8. Gordon D. J., Probstfield J. L., Garrison R. J., Neaton J. D., Castelli W. P., Knoke J. D., Jacobs D. R., Jr, Bangdiwala S., Tyroler H. A. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989 Jan;79(1):8–15. doi: 10.1161/01.cir.79.1.8. [DOI] [PubMed] [Google Scholar]
  9. Hoffer M. J., Bredie S. J., Boomsma D. I., Reymer P. W., Kastelein J. J., de Knijff P., Demacker P. N., Stalenhoef A. F., Havekes L. M., Frants R. R. The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia. Atherosclerosis. 1996 Jan 26;119(2):159–167. doi: 10.1016/0021-9150(95)05641-6. [DOI] [PubMed] [Google Scholar]
  10. Jemaa R., Fumeron F., Poirier O., Lecerf L., Evans A., Arveiler D., Luc G., Cambou J. P., Bard J. M., Fruchart J. C. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde. J Lipid Res. 1995 Oct;36(10):2141–2146. [PubMed] [Google Scholar]
  11. Ma Y., Ooi T. C., Liu M. S., Zhang H., McPherson R., Edwards A. L., Forsythe I. J., Frohlich J., Brunzell J. D., Hayden M. R. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J Lipid Res. 1994 Jun;35(6):1066–1075. [PubMed] [Google Scholar]
  12. Minnich A., Kessling A., Roy M., Giry C., DeLangavant G., Lavigne J., Lussier-Cacan S., Davignon J. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent. J Lipid Res. 1995 Jan;36(1):117–124. [PubMed] [Google Scholar]
  13. Nordestgaard B. G., Wootton R., Lewis B. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol. 1995 Apr;15(4):534–542. doi: 10.1161/01.atv.15.4.534. [DOI] [PubMed] [Google Scholar]
  14. Olivecrona G., Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol. 1995 Oct;6(5):291–305. doi: 10.1097/00041433-199510000-00009. [DOI] [PubMed] [Google Scholar]
  15. Reymer P. W., Gagné E., Groenemeyer B. E., Zhang H., Forsyth I., Jansen H., Seidell J. C., Kromhout D., Lie K. E., Kastelein J. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet. 1995 May;10(1):28–34. doi: 10.1038/ng0595-28. [DOI] [PubMed] [Google Scholar]
  16. Reymer P. W., Groenemeyer B. E., Gagné E., Miao L., Appelman E. E., Seidel J. C., Kromhout D., Bijvoet S. M., van de Oever K., Bruin T. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet. 1995 Sep;4(9):1543–1549. doi: 10.1093/hmg/4.9.1543. [DOI] [PubMed] [Google Scholar]
  17. Syvänne M., Antikainen M., Ehnholm S., Tenkanen H., Lahdenperä S., Ehnholm C., Taskinen M. R. Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. J Lipid Res. 1996 Apr;37(4):727–738. [PubMed] [Google Scholar]
  18. Talmud P., Tybjaerg-Hansen A., Bhatnagar D., Mbewu A., Miller J. P., Durrington P., Humphries S. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis. 1991 Aug;89(2-3):137–141. doi: 10.1016/0021-9150(91)90053-6. [DOI] [PubMed] [Google Scholar]
  19. The Copenhagen City Heart Study. Osterbroundersøgelsen. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). The Copenhagen City Heart Study Group. Scand J Soc Med Suppl. 1989;41:1–160. [PubMed] [Google Scholar]
  20. Zhang H., Reymer P. W., Liu M. S., Forsythe I. J., Groenemeyer B. E., Frohlich J., Brunzell J. D., Kastelein J. J., Hayden M. R., Ma Y. Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1695–1703. doi: 10.1161/01.atv.15.10.1695. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES